‘Very high’ COVID-19 positivity rate in 15 Luzon provinces -- OCTA | Inquirer News

‘Very high’ COVID-19 positivity rate in 15 Luzon provinces — OCTA

/ 08:09 AM August 08, 2022

covid-19 test cases daily

(REUTERS)

MANILA, Philippines — “Very high” COVID-19 positivity rates were noted in 15 provinces in Luzon over the past week, OCTA Research fellow Guido David said Monday.

David, in a tweet, said that as of August 6, 2022,  positivity rates in the provinces of Albay, Benguet, Cagayan, Camarines Sur, Cavite, Isabela, La Union, Laguna, Nueva Ecija, Pampanga, Pangasinan, Quezon, Rizal, Tarlac, Zambales are deemed to be “very high”.

ADVERTISEMENT

According to data shared by David, the highest recorded was in Camarines Sur at 48.7 percent followed by Isabela (47.6 percent), Tarlac (41.9 percent), Nueva Ecija (38.4 percent), Pampanga (35 percent), and Laguna (33.2 percent).

FEATURED STORIES

Cagayan registered a 30.5 percent positivity rate, followed by La Union  (29.4 percent),  Zambales (28.6 percent), Albay (28.2 percent),  Quezon (25.1 percent), Pangasinan (25 percent), Benguet (22 percent), Cavite (21.1 percent) and Rizal (18.8 percent)

Meanwhile, David also reported that the positivity rate in Metro Manila also increased from 15.5 percent on August 30 to 17.5 percent as of August 6.

 gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS:  Guido David, COVID-19, OCTA Research

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.